4//SEC Filing
Watson Ashley 4
Accession 0001225208-18-008941
CIK 0000310158other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 5:33 PM ET
Size
9.2 KB
Accession
0001225208-18-008941
Insider Transaction Report
Form 4
Watson Ashley
SVP Chief Ethics & Com Officer
Transactions
- Award
Restricted Stock Unit
2018-05-04+2,597→ 2,597 totalFrom: 2019-05-04Exp: 2021-05-04→ Common Stock (2,597 underlying) - Award
Stock Option (right to buy)
2018-05-04+18,298→ 18,298 totalExercise: $57.75From: 2019-05-04Exp: 2028-05-03→ Common Stock (18,298 underlying)
Holdings
- 9,631.721
Common Stock
- 189.581(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (5)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through May 1, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
- [F5]The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001708109
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 5:33 PM ET
- Size
- 9.2 KB